Kuwait Dental Board Periodontics cheat sheet

Gingival fiber groups: dentogingival, dentoperiosteal, alveologingival, circular, transseptal; transseptal fibers regenerate earliest after surgery, circular fibers are the only group not attached to tooth or bone.

Biologic width (supracrestal attached tissues) averages about 2.04 mm: junctional epithelium 0.97 mm plus connective tissue attachment 1.07 mm; a minimum of 3 mm between restoration margin and bone is the classic rule to avoid violation.

Junctional epithelium is nonkeratinized, 15-30 cells coronally tapering to 1-3 cells apically, with wide intercellular spaces and few desmosomes, permitting leukocyte migration and permeability.

Gingival connective tissue is about 60% collagen (mainly type I, with III, IV, V), 5% fibroblasts, 30-35% vessels/nerves, and 5% ground substance; the lamina propria has no true submucosa.

Alveolar bone is bundle bone where Sharpey fibers insert; physiologic mesial drift and continuous eruption depend on the transeptal fiber apparatus and the periodontal ligament.

Periodontal ligament width is 0.15-0.38 mm, narrowest at mid-root; principal fibers are alveolar crest, horizontal, oblique (most numerous, principal support against axial load), apical, and interradicular.

Gingival sulcus depth in health is 0-3 mm; sulcular epithelium is nonkeratinized and lacks rete pegs, whereas oral gingival epithelium is keratinized or parakeratinized with rete pegs.

Col is the saddle-shaped interdental gingiva, nonkeratinized and thin, present when adjacent teeth contact; it is the site most vulnerable to plaque-induced breakdown.

Cementum is avascular, lacks innervation, and does not remodel; acellular extrinsic fiber cementum predominates in the coronal half and anchors principal fibers, while cellular cementum is found apically and in furcations.

Plaque biofilm formation follows ordered succession: initial colonizers (Streptococcus oralis, S. mitis, Actinomyces) adhere to the acquired pellicle, then Fusobacterium nucleatum bridges to late colonizers including Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola (the red complex).

Keystone-pathogen concept: P. gingivalis at low abundance can dysregulate the community, subvert complement (gingipains degrade C3, C5) and evade TLR4-driven inflammation, converting a symbiotic biofilm into a dysbiotic one.

Host response drives destruction: IL-1, TNF-alpha, IL-6, PGE2, and MMP-8/MMP-9 mediate connective tissue and bone loss; RANKL from T/stromal cells activates osteoclasts while osteoprotegerin is the decoy receptor.

Risk factors with strong evidence: smoking (dose-dependent, suppresses gingival bleeding and neutrophil function), poorly controlled diabetes (AGE-RAGE axis), and genetic predisposition (IL-1 polymorphism evidence is modest); plaque is necessary but not sufficient.

Calculus is mineralized plaque (hydroxyapatite, calcium phosphate) and is always covered by unmineralized biofilm; it is a retentive, not directly destructive, factor.

Local contributing factors: overhanging restorations, root grooves/furcation anatomy, enamel pearls, cervical enamel projections, open contacts, and orthodontic appliances.

Gingivitis is reversible inflammation confined to gingiva with no attachment loss; periodontitis requires clinical attachment loss with inflammation and is defined by loss of periodontal attachment and alveolar bone.

Abscess formation, necrotizing periodontal disease (pain, bleeding, pseudomembrane, fetor, punched-out papillae), and herpes/zoster or drug-related lesions are key differentials for acute periodontal pain.

2018 World Workshop classification uses staging (I-IV) for severity and extent and grading (A-C) for progression; Stage is based on interdental CAL at the worst site, plus radiographic bone loss and tooth loss from periodontitis.

Stage I: CAL 1-2 mm, RBL coronal third <15%; Stage II: CAL 3-4 mm, RBL coronal third 15-33%; Stage III: CAL >=5 mm, RBL extending to middle third and beyond, <=4 teeth lost; Stage IV: CAL >=5 mm with >=5 teeth lost, plus complex rehabilitation needs (masticatory dysfunction, bite collapse, drifting, <20 teeth).

Grade uses % bone loss/age: Grade A <0.25, Grade B 0.25-1.0, Grade C >1.0; modifiers include smoking (<10 cig/day or former >=5 years = B; >=10/day = C) and HbA1c (<7.0% = B; >=7.0% = C).

Extent descriptor: localized = <30% of teeth involved, generalized = >=30%, or molar-incisor pattern; staging is not altered by extent.

Periodontal screening uses the CPITN/PSR sextant codes 0-4: code 0 healthy, 1 bleeding, 2 calculus/overhang, 3 pocket 3.5-5.5 mm, 4 pocket >=5.5 mm; code 3 or 4 triggers full charting.

Probing depth is measured from gingival margin to sulcus base; CAL = probing depth + recession (or minus gingival enlargement); bone sounding under anesthesia estimates attachment and crown lengthening needs.

Radiographic assessment: bitewings for crestal bone, periapicals for furcations and vertical defects, panoramic for screening; bone loss is best expressed as a percentage of root length and compared with the CEJ.

Mobility is graded I (<=1 mm), II (>1 mm but <2 mm), III (>=2 mm or depressible); furcation involvement uses Glickman I-IV or Hamp I-III; bleeding on probing has high negative predictive value for stability but low positive predictive value.

Scaling and root planing (SRP) aims to remove supra- and subgingival biofilm and calculus and to detoxify root surfaces; systematic reviews show 0.5-1.5 mm probing depth reduction and 0.3-0.6 mm CAL gain, with greater benefit in deeper pockets.

SRP is usually performed by quadrant or sextant in 1-2 visits with local anesthesia; re-evaluation at 4-8 weeks determines residual pockets, bleeding, and need for surgery.

Systemic antibiotics: adjunctive amoxicillin 500 mg + metronidazole 400-500 mg three times daily for 7 days is the best-supported regimen for Grade C/generalized Stage III-IV periodontitis; azithromycin 500 mg daily for 3 days is an alternative in penicillin allergy.

Antibiotics are not indicated for routine Stage I-II periodontitis; they must follow mechanical debridement and should be reserved for specific clinical situations to limit resistance.

Locally delivered agents (chlorhexidine chip, minocycline microsphere, doxycycline gel) give small additional PD reduction (about 0.3-0.5 mm) and are adjuncts, not substitutes for SRP.

Sub-antimicrobial-dose doxycycline 20 mg twice daily for 3-9 months inhibits MMPs (host modulation) and may be used as an adjunct in selected patients; it is not intended as an antibiotic.

Chlorhexidine 0.12-0.2% is the gold-standard antiplaque rinse (substantivity about 12 hours) but causes staining, taste alteration, and calculus; it is used short-term after surgery or when brushing is impossible.

Other adjuncts: essential oils, cetylpyridinium chloride, and triclosan rinses have modest evidence; powered toothbrushes (oscillating-rotating) and interdental brushes reduce plaque more than manual brushing alone.

Smoking cessation and glycemic control are essential adjuncts; SRP outcomes are poorer in smokers, and HbA1c reduction improves periodontal outcomes.

Indications for periodontal surgery: residual pockets >=5-6 mm with bleeding after phase I, furcation involvement, mucogingival problems, and need for regeneration or crown lengthening; surgery is not a substitute for plaque control.

Modified Widman flap (open debridement) preserves as much tissue as possible and gives pocket reduction with less recession; osseous resective surgery (apically positioned flap with ostectomy/osteoplasty) is used for shallow to moderate defects and to re-establish positive architecture.

Guided tissue regeneration uses barrier membranes (PTFE, collagen, polylactide) to exclude epithelium and allow periodontal ligament and bone cells to repopulate; best outcomes in intrabony defects >=3 mm and Class II furcations.

Regenerative materials: bone grafts (autograft, allograft, xenograft, alloplast), enamel matrix derivative (EMD), platelet-rich fibrin, and growth factors; EMD and GTR show similar or additive benefit in intrabony defects.

Root conditioning with EDTA, citric acid, or tetracycline removes smear layer and exposes collagen; evidence for clinical benefit is limited but it is used in regenerative protocols.

Furcation treatment: Class I scaling/plasty; Class II GTR or tunnel preparation; Class III-IV tunneling, root amputation, or extraction; mandibular Class II responds better to regeneration than maxillary.

Flap design principles: adequate access, full-thickness or split-thickness, vertical releasing incisions through interdental papilla avoided for esthetics, and tension-free closure with sutures.

Postoperative care: avoid brushing the surgical site for 1-2 weeks, use chlorhexidine rinse, control pain, and avoid smoking; healing by repair occurs with long junctional epithelium when regeneration fails.

Crown lengthening requires 3 mm from restoration margin to bone (biologic width) and may need osseous resection; esthetic crown lengthening must account for gingival display and smile line.

Peri-implant mucositis is reversible inflammation confined to soft tissue with bleeding on probing and no bone loss; peri-implantitis is inflammation with progressive bone loss beyond initial remodeling.

Peri-implantitis prevalence is high in long-term follow-up (approximately 10-20% of implants at patient level depending on case definitions); smoking, history of periodontitis, poor plaque control, and lack of maintenance are major risk factors.

Implant health criteria: no bleeding on probing, no swelling, no bone loss beyond initial remodeling, and pocket depths usually <=5 mm; probing is safe with light force (0.25 N).

Peri-implant tissues lack a periodontal ligament and cementum, so the seal is junctional epithelium plus a connective tissue scar poor in collagen and rich in inflammatory cells; blood supply is periosteal.

Treatment of peri-implantitis: nonsurgical debridement alone is usually insufficient; surgical access with implant surface decontamination (mechanical, chemical, laser) plus GTR or bone graft in selected defects; implantoplasty for suprabony defects.

Implant placement timing: Type 1 immediate, Type 2 early (2-8 weeks), Type 3 early delayed (8-16 weeks), Type 4 late (>16 weeks); immediate placement requires adequate socket walls and no acute infection.

Osseointegration requires primary stability, biocompatible surface (SLA, anodized), and undisturbed healing; minimum bone width about 5-6 mm and height about 8-10 mm for standard implants.

Risk factors for implant failure: smoking, uncontrolled diabetes, bruxism, poor bone quality (posterior maxilla), and history of treated periodontitis; maintenance every 3-6 months is recommended for periodontitis-susceptible patients.

Mucositis is treated with professional debridement and improved oral hygiene; untreated mucositis can progress to peri-implantitis.

Gingival recession classification: Miller I (no interdental loss, complete coverage possible), II (no interdental loss, complete coverage possible), III (interdental loss, partial coverage), IV (severe loss, no coverage); Cairo uses recession type RT1-RT3.

Gingival thickness: thin biotype <1.0-1.5 mm and narrow keratinized tissue (<2 mm) increase recession risk; a minimum of 2 mm keratinized tissue with 1 mm attached gingiva is the classic threshold for stability.

Root coverage procedures: coronally advanced flap (CAF) with connective tissue graft is the best-documented, with mean coverage about 80-90% in Miller I-II; pedicle flaps (lateral, double papilla) and free gingival graft are alternatives.

Free gingival graft increases keratinized tissue but gives little root coverage; CTG provides both coverage and thickness; acellular dermal matrix and enamel matrix derivative are alternatives with lower predictability.

Tunnel technique and VISTA allow coverage with less donor morbidity; results depend on flap thickness, blood supply, and absence of tension.

Esthetic crown lengthening: measure bone sounding, plan 3 mm biologic width, and use a surgical guide; gingivectomy alone is limited to cases with adequate attached gingiva and bone level.

Reducing black triangles: interdental papilla presence depends on the distance from contact point to bone (<=5 mm predictable, >6 mm unlikely) and interproximal root distance; treatments include orthodontics, restorations, or papilla reconstruction.

Soft tissue grafting for site development before implants: CTG or free gingival graft to increase keratinized tissue and ridge volume; timing with implant placement affects predictability.

Postoperative care after mucogingival surgery: avoid mechanical trauma, use chlorhexidine, and consider systemic antibiotics in extensive grafting.

Bidirectional relationship: periodontitis is associated with diabetes (HbA1c reduction of about 0.3-0.4% with periodontal therapy), cardiovascular disease, adverse pregnancy outcomes, and respiratory disease.

Diabetes: hyperglycemia increases AGEs and RAGE, impairs neutrophil function and collagen synthesis, and worsens periodontal destruction; periodontal therapy improves glycemic control especially in type 2 diabetes.

Cardiovascular disease: periodontal inflammation is linked to atherosclerosis via inflammatory mediators and bacteremia; the evidence is associative, and causality is not established.

Pregnancy: periodontitis is associated with preterm birth and low birth weight in observational studies; treatment is safe in the second trimester, but randomized trials have not shown consistent reduction in adverse outcomes.

Smoking: dose-dependent risk, heavier in current smokers; cessation improves outcomes and should be part of periodontal therapy; nicotine replacement and behavioral counseling are first-line.

Medication-related osteonecrosis of the jaw (MRONJ): associated with bisphosphonates, denosumab, and antiangiogenic agents; risk rises with IV therapy and duration; conservative management and avoiding elective surgery in high-risk patients are key.

Drug-influenced gingival enlargement: phenytoin, cyclosporine, and calcium channel blockers (nifedipine, amlodipine); management includes plaque control, drug substitution, and surgery if needed.

Other systemic links: osteoporosis, rheumatoid arthritis, obesity, and chronic kidney disease; hematologic conditions (leukemia, neutropenia) can present with gingival bleeding or ulceration and require referral.

Periodontal disease and COVID-19 or other infections: associations reported but not causal; maintain standard precautions and risk assessment.

Supportive periodontal care (SPC) intervals are individualized: 3 months for high-risk patients (periodontitis stage III-IV, smokers, diabetes, poor plaque control), 3-6 months for moderate risk, and 6-12 months for low risk.

Lang and Tonetti risk assessment uses percentage bleeding on probing, number of residual pockets >=5 mm, tooth loss, bone loss/age, systemic and genetic factors, and environmental factors (smoking) to assign low, moderate, or high risk.

Maintenance outcomes: patients compliant with SPC have less attachment loss and tooth loss than noncompliant patients; recall includes probing depths, bleeding, mobility, furcations, plaque, and radiographs as indicated.

Prognosis classification: good (adequate bone support, no inflammation, controlled risk), fair (reduced support but maintainable), poor (advanced bone loss, furcation, mobility), questionable, and hopeless (untreatable, extraction indicated).

Tooth prognosis factors: attachment loss percentage, mobility, furcation involvement, root form, crown-to-root ratio, endodontic status, and patient compliance.

Outcome measures: probing depth reduction, CAL gain, bleeding on probing reduction, plaque score, radiographic bone stability, tooth survival, and patient-reported outcomes.

Re-evaluation after active therapy at 6-8 weeks, then 3 months; residual pockets >=5 mm with bleeding should be considered for further therapy or surgery.

Tooth loss in treated periodontitis is driven by residual deep pockets, smoking, poor compliance, and furcation involvement; maintenance frequency is the strongest modifiable factor.

Peri-implant maintenance parallels periodontal maintenance: assess bleeding, probing depth, bone level, and occlusion; treat mucositis early to prevent peri-implantitis.

Evidence hierarchy: systematic reviews and meta-analyses of randomized controlled trials > RCTs > cohort > case-control > cross-sectional > case reports; clinical decisions integrate evidence, expertise, and patient values.

PICO framework: Population, Intervention, Comparison, Outcome; used to formulate answerable clinical questions and structure literature searches.

Sensitivity = true positives / (true positives + false negatives); specificity = true negatives / (true negatives + false positives); positive predictive value depends on prevalence.

Randomization reduces selection bias; allocation concealment and blinding reduce performance and detection bias; intention-to-treat analysis preserves randomization.

Statistical tests: t-test for continuous normal data, chi-square for categorical, ANOVA for >2 groups, nonparametric alternatives (Mann-Whitney, Kruskal-Wallis) when assumptions fail.

p-value is the probability of observing the result (or more extreme) if the null hypothesis is true; it is not the probability that the null is true; alpha 0.05 is convention.

Confidence interval expresses precision; a 95% CI excluding the null value corresponds to p<0.05; effect size (mean difference, risk ratio, odds ratio) is more clinically meaningful than p alone.

Systematic review quality is assessed with AMSTAR or Cochrane risk-of-bias tools; heterogeneity is quantified with I-squared; publication bias is assessed with funnel plots and Egger test.

Critical appraisal of therapy studies: randomization, allocation concealment, blinding, baseline comparability, follow-up completeness, and applicability to the patient.

Informed consent requires disclosure of diagnosis, proposed treatment, alternatives, risks, benefits, and consequences of no treatment; it must be voluntary and documented.

Autonomy, beneficence, nonmaleficence, justice, and confidentiality are core ethical principles; competence and scope of practice define professional boundaries.

Record keeping: contemporaneous, legible, signed, and complete notes including periodontal charting, radiographs, consent, and communication; records are legal documents.

Patient safety: identify patients (two identifiers), verify allergies and medications, use proper positioning and ergonomics, and manage medical emergencies (syncope, hypoglycemia, anaphylaxis, angina).

Antibiotic stewardship: prescribe only when indicated, choose narrow spectrum, and complete the course; avoid unnecessary prophylaxis except for specified cardiac conditions.

Confidentiality and privacy: share information only with consent or legal requirement; use secure systems for records and communication.

Referral and second opinion: recognize limits of competence and refer complex cases (e.g., severe periodontitis, mucogingival surgery, implant complications) appropriately.

Conflict of interest and honesty: disclose financial interests, avoid misleading claims, and base advertising on verifiable evidence.

Cultural competence and communication: use interpreters, plain language, and shared decision-making; document patient preferences and refusal.

Standard precautions apply to all patients: hand hygiene, gloves, mask, eye protection, and gown; hand hygiene is the single most important measure.

Sterilization: autoclave at 121 degrees C at 15 psi for 15-20 minutes or 134 degrees C for 3-4 minutes; monitor with biological indicators (spore tests) weekly and chemical indicators each load.

Critical items (surgical instruments, scalers) must be sterilized; semicritical items (mirrors, radiograph holders) require sterilization or high-level disinfection; noncritical surfaces require low-level disinfection.

Ultrasonic scalers generate aerosols; use high-volume evacuation, rubber dam or preprocedural rinse, and adequate ventilation; hand scaling reduces aerosol.

Sharps safety: never recap needles with two hands; use safety devices and sharps containers; post-exposure protocol includes washing, reporting, and HIV/HBV/HCV testing and prophylaxis.

Hepatitis B vaccination is recommended for dental personnel; HBV is the most transmissible bloodborne pathogen in dentistry; post-exposure prophylaxis depends on immune status.

Practice management: scheduling, recall systems, fee setting, insurance coding, and team roles; periodontal charting and radiographs support documentation and billing.

Ergonomics: proper operator and patient positioning, loupes, and microbreaks reduce musculoskeletal disorders; four-handed dentistry improves efficiency and reduces fatigue.

Waste segregation: sharps in rigid containers, infectious waste in designated bags, and amalgam waste in closed containers per local regulations.